Clinical trials
Clinical Study clinical trials
Below are recruiting clinical study clinical trials, each written for real people, not researchers. We’re tracking 1,811 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07156695Recruiting
Deep filling study for tooth decay and gum health
This trial tests a technique called deep marginal elevation for fixing deep cavities near the gumline. It aims to see if this method affects your gum health compared to a healthy tooth on the other side.
Tanta, El-GharbiaAges 18–60 - NCT05822427Recruiting
Long-term follow-up for people who received azer-cel
This study checks how people do over a longer period after receiving azer-cel in an Imugene trial. It helps doctors understand long-term safety and health outcomes, even if you are feeling well now.
Culver City, CaliforniaAges 18 years+ - NCT06660056RecruitingPhase 1
GC001 injection for returning or growing high-grade brain tumors
This trial tests a new drug, GC001, injected directly into the tumor in people with high-grade gliomas (WHO grade 3 or 4) that have come back or are growing. It may be an option if standard treatments have stopped working.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06974123Enrolling by invitationPhase 1/Phase 2
Testing a new oral drug for radiation proctitis
This trial tests an oral drug called Teslanbaicin for people who have pelvic cancer and developed radiation proctitis (inflammation of the rectum from radiation therapy). The goal is to see if it is safe and helps heal the inflammation.
Xinxiang, HenanAges 18 years+ - NCT06508307RecruitingPhase 1
A study of an injected virus for advanced solid tumors
This trial tests a new treatment where a virus (GC001) is injected directly into a tumor. The virus is designed to attack cancer cells and may help people with advanced solid tumors that haven't responded to other treatments.
Zhengzhou, HenanAges 18–75 - NCT06042803Recruiting
Study on medicine levels in breastmilk
This study looks at how medicines pass into breastmilk. It helps understand the safety of medications while breastfeeding. If you take medicine and breastfeed, this study may be an option for you.
Leuven, Vlaams-BrabantAges 18 years+ - NCT07491744Enrolling by invitation
Stroke and TIA study on heart and blood vessel health
This study looks at the causes of stroke and TIA by doing extra tests on patients admitted to the hospital. It aims to better understand and prevent future heart and blood vessel problems.
Stockholm, Stockholm CountyAges 18 years+ - NCT07429617Recruiting
Darkness retreat study for healthy adults
This study explores the effects of spending time in complete darkness. You might join if you are generally healthy, not taking any mental health medication, and not currently in therapy.
Poznan, WielkopolskaAges 30–50 - NCT06290024Recruiting
Nerve pain study: tracking long-term symptoms
This study follows people with nerve pain over time to learn more about their condition. You will not receive a new treatment, but your data will help doctors understand neuropathic pain better.
Shanghai, YangpuAges 18–85 - NCT04393259Recruiting
Pregnancy study for people with prior pregnancy loss
This study is for pregnant women who have previously experienced a stillbirth, the death of a baby shortly after birth, or a late pregnancy termination. The goal is to learn about care and support needs for these pregnancies and outcomes, which may help improve future guidance.
Manchester, Greater ManchesterAges 16–50 - NCT07290257RecruitingPhase 4
Long-term safety study of Livmarli for Alagille syndrome or PFIC
This study looks at the long-term safety and effects of Livmarli (maralixibat) in children with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC). It may help understand how well the medicine works over time for itching and other symptoms.
BrusselsAges 2 months+ - NCT07224685Recruiting
Mayo heart & voice health study with phone and watch
This study uses your iPhone and Apple Watch to collect heart and voice data to learn more about cardiovascular health. It may help improve how doctors monitor heart conditions.
Rochester, MinnesotaAges 18 years+ - NCT07009847Recruiting
Study of the R21/Matrix-M malaria vaccine
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
Bousse, Burkina FasoAges 5 months+ - NCT05335668Recruiting
Brain scan study of pain changes after stroke
This study looks at how brain wiring changes in people who have central post-stroke pain. It uses clinical checks and detailed brain scans (including a 7T MRI) to understand what may be driving the pain and how the brain changes over time.
BernAges 18–75 - NCT07292441RecruitingPhase 3
Long-term weight loss study for trial participants
This study is for people who finished a previous weight loss trial and want to continue treatment with an injectable medication GZR18. It tests how well the medicine works over a longer period.
Beijing, Beijing MunicipalityAges 18–75 - NCT06588101Recruiting
Improving ICU family member trial participation
This trial tests different ways to help families of ICU patients join and stay in research studies. If you have a loved one in the ICU for more than 48 hours, you may be able to help find better ways to support families like yours.
Montreal, QuebecAges 18 years+ - NCT04631133Recruiting
Study of outcomes after surgery using the LISA implant
This study follows adults who get back surgery using the LISA implant to see how well they do afterward and how outcomes change over time. It focuses on people whose long-term, non-surgical care did not relieve low-back pain from specific age-related disc changes.
SilkeborgAges 18 years+ - NCT05041556Recruiting
Study of RTS,S malaria vaccine evidence in local areas
This study checks how well evidence about the RTS,S/AS01 malaria vaccine helps inform health policy. You may be included if you live in a specific local area and your child is the right age for the vaccine schedule, and you agree to participate.
KintampoAges 6 months–4.9 years - NCT06185920Recruiting
A study of phage therapy for severe infections
This study looks at how well phage therapy (a virus that kills bacteria) works for severe infections. It's for people who received this treatment at a specific hospital in France.
LyonAges Any age - NCT06996704RecruitingPhase 1
Study of AK0610 in healthy adults
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
Jinan, ShandongAges 18–50 - NCT07307586RecruitingPhase 3
Azvudine for new hepatitis B patients
This study tests a new pill (azvudine) to see if it can cure chronic hepatitis B in people who have never been treated before. It is for those with active infection and elevated liver enzymes.
Zhengzhou, HenanAges 18–65 - NCT07308574RecruitingPhase 4
Ravulizumab for aHUS patients
This trial tests the drug ravulizumab for people with aHUS (a rare blood and kidney condition). It aims to see if the drug can help improve blood counts and kidney function.
Bunkyō CityAges 18 years+ - NCT04093570Enrolling by invitationPhase 2
Extension study for people continuing ASTX727 from a prior trial
This study checks whether continuing ASTX727 for people who already benefited from it in an earlier Taiho study is safe and effective. It may be an option if you stayed on ASTX727 at the end of your parent study and your doctor felt it was helping you.
Fountain Valley, CaliforniaAges 18 years+ - NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Phoenix, ArizonaAges 18 years+
Hear when a new Clinical Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical study?
- Yes. Clin2 currently lists 1,811 recruiting clinical study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.